Microba Life Sciences (ASX:MAP) EV-to-EBITDA : -3.66 (As of May. 18, 2024)

Microba Life Sciences EV-to-EBITDA Chart

Competitive Comparison of Microba Life Sciences's EV-to-EBITDA

For the Diagnostics & Research subindustry, Microba Life Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microba Life Sciences's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's EV-to-EBITDA falls into.

Microba Life Sciences EV-to-EBITDA Calculation

Microba Life Sciences's EV-to-EBITDA for today is calculated as:

Microba Life Sciences's current Enterprise Value is A$60.66 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Microba Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-16.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences  (ASX:MAP) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Microba Life Sciences's PE Ratio for today is calculated as:

Microba Life Sciences's share price for today is A$0.195.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Microba Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.050.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Microba Life Sciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description